Envestnet Asset Management Inc. Sells 249,934 Shares of Haleon PLC Sponsored ADR (NYSE:HLN)

Envestnet Asset Management Inc. lowered its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 3.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,380,373 shares of the company's stock after selling 249,934 shares during the period. Envestnet Asset Management Inc. owned about 0.16% of Haleon worth $75,944,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its stake in Haleon by 8.8% in the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock valued at $131,000 after buying an additional 1,041 shares in the last quarter. Simplicity Wealth LLC increased its holdings in shares of Haleon by 7.9% during the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock worth $159,000 after buying an additional 1,135 shares during the last quarter. Haverford Trust Co increased its holdings in shares of Haleon by 5.0% during the 4th quarter. Haverford Trust Co now owns 25,842 shares of the company's stock worth $247,000 after buying an additional 1,233 shares during the last quarter. Bessemer Group Inc. increased its holdings in Haleon by 5.9% in the 4th quarter. Bessemer Group Inc. now owns 22,301 shares of the company's stock valued at $212,000 after purchasing an additional 1,236 shares in the last quarter. Finally, United Capital Financial Advisors LLC grew its stake in shares of Haleon by 3.5% during the fourth quarter. United Capital Financial Advisors LLC now owns 37,475 shares of the company's stock valued at $358,000 after acquiring an additional 1,266 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Haleon Stock Down 0.8%

NYSE:HLN traded down $0.08 during trading hours on Monday, reaching $9.89. The company's stock had a trading volume of 14,095,377 shares, compared to its average volume of 13,385,545. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.98 and a quick ratio of 0.78. Haleon PLC Sponsored ADR has a one year low of $8.68 and a one year high of $11.42. The business's 50-day moving average is $10.70 and its 200-day moving average is $10.17. The company has a market cap of $44.41 billion, a price-to-earnings ratio of 25.35, a price-to-earnings-growth ratio of 2.88 and a beta of 0.25.

Analyst Upgrades and Downgrades

HLN has been the subject of a number of research reports. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research note on Saturday. Morgan Stanley upgraded Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research report on Friday, May 9th. BNP Paribas raised Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a report on Tuesday, May 27th. Finally, Barclays reaffirmed an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.